Enveric Biosciences, Inc. ENVB
NASDAQ · United States · Health Technology
$1.46-0.03 (-1.68%)
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
| Quarter | Report date | Actual EPS | Estimated EPS | EPS surprise | Price reaction |
|---|---|---|---|---|---|
| Q2 2026 | 2026-03-27 | 0.85 | -55.80 | +101.5% | -3.8%$1.86→$1.79 |
| Q4 2024 | 2025-03-28 | -2.03 | -2.76 | +26.4% | — |
| Q2 2024 | 2024-08-12 | -45.00 | -99.00 | +54.5% | — |
| Q4 2023 | 2024-03-26 | -191.31 | -314.10 | +39.1% | — |
The price reaction is the change from the last close before the announcement date to the first close after it - the report may land before the open, during the session or after the close, so this window covers all three. Not investment advice.